BASHAN DROR (President & CEO) purchased 94.9% of their position (64.52K shares) of PROTALIX BIOTHERAPEUTICS, INC. on the open market
Open‑market purchase worth $90.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/20/2023ACC: 0001415889-23-014454
DirectorOfficer· President & CEO
Since Jun 2019
+64.52K
Net shares
Net buyer
$90.5K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
64.52K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+48.39K
Price / share
$1.40
Trade value
$67.74K
% of position
71.2%
10/19/2023
68K→116.39K
Common Stock
Direct
Shares
+16.13K
Price / share
$1.41
Trade value
$22.74K
% of position
13.9%
10/19/2023
116.39K→132.52K
Total
Net shares
+64.52K
Net value
$90.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/19/2023 | P · Purchase | +48.39K | $1.40 | $67.74K | 71.2% | 68K | 116.39K |
| Common Stock Direct | 10/19/2023 | P · Purchase | +16.13K | $1.41 | $22.74K | 13.9% | 116.39K | 132.52K |
| Total | +64.52K | $90.48K | ||||||
Derivative Transactions0
No derivative transactions reported